HCPCS Level II code J7613 describes an FDA-approved, non-compounded albuterol inhalation solution supplied as a 1 mg unit dose and intended for administration through durable medical equipment; service type is inhalation bronchodilator administration and the typical site of service is outpatient or home settings where DME nebulizer therapy is used.

For related coverage guidance, see recent payer policy updates: Epithelial Cell Cytology in Breast Cancer Risk Assessment, Chimeric Antigen Receptor (CAR) T-Cell Therapy, Antibody-Drug Conjugates.